Table 4.

Distribution of samples and proportion of failure^* by therapeutic indications, 2003–2013

Therapeutic indication	Total samples	Number of failed samples (%)
Antimalarial	7,333	478 (6.5)
Antibiotic	5,174	150 (2.9)
Antituberculosis	1,749	95 (5.4)
Antiretroviral	324	35 (10.8)
Others	483	90 (18.6)
Total	15,063	848 (5.6)

^*Failed medicines are classified as those that failed visual inspection, were expired at the point of collection, failed verification and/or confirmatory testing. Confirmatory testing failures include failed assay (identity), dissolution, or impurity testing.